eIF3a improve cisplatin sensitivity in ovarian cancer by regulating XPC and p27Kip1 translation
Yu Zhang(Wannan Medical College), Zhaoqian Liu(Central South University), Shufen Zhang(Hangzhou Medical College), Cai-Yi Zhang(Xuzhou Medical College), Jingjing Yu(Central South University), Yi Zhang(Central South University), Lanqin Cao(Central South University), Yan Tian(Plastic Surgery Hospital), Hong‐Hao Zhou(Central South University), Chenyue Qian(Central South University), Ji‐Ye Yin(Central South University), Zhengzheng Li(Wenzhou Medical University), Wei Zhang(Central South University)
Cited by 47
Related Papers
Exosomes derived from mesenchymal stem cells reverse EMT via TGF-β1/Smad pathway and promote repair of damaged endometrium
|Stem Cell Research & Therapy|2019|294
MicroRNA-21 down-regulates the expression of tumor suppressor PDCD4 in human glioblastoma cell T98G
|Cancer Letters|2008|216
Niraparib maintenance therapy in patients with platinum-sensitive recurrent ovarian cancer using an individualized starting dose (NORA): a randomized, double-blind, placebo-controlled phase III trial☆
|Annals of Oncology|2021|212